Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) — The “Huntington Disease Treatment Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering.
With the global healthcare community focused on managing genetic disorders such as Huntington’s disease, this report provides critical insights into the burgeoning industry predicted to reach US$ 1.285 billion by 2030, experiencing a compound annual growth rate (CAGR) of 16.53% from 2023 to 2030.
The burgeoning Huntington’s Disease Treatment Market is witnessing an uptick due to an increase in the geriatric population and rising instances of genetic disorders. It is becoming ever more crucial with the expanding pool of patients presenting symptoms such as movement difficulties, cognitive impairment, and issues swallowing.
Approved Drugs Take Spotlight in Huntington’s Disease Market
Huntington’s Disease Treatment Market by Drug Type:
- Approved Drugs
- Off-label Drugs
Approved drugs for Huntington’s disease underline the market, being meticulously tested and verified for symptom management efficacy in this neurodegenerative disease. As the search for more effective treatments continues, these medications remain indispensable in alleviating patient suffering and enhancing the quality of life.
Drug Stores and Retail Pharmacies: Emerging as Key Players
By End User:
- Hospital Pharmacies
- Drug Store & Retail Pharmacy
- Online Pharmacy
Drug stores and retail pharmacies are surfacing as vital hubs in the treatment market. They stand out for providing accessible therapeutic options, which is increasingly important due to the progressive nature of Huntington’s disease.
United States Leads in Global Huntington’s Disease Treatment Arena
The U.S. remains a strong contender in the market share for Huntington’s Disease Treatment, courtesy of its extensive healthcare and pharmaceutical innovation. This positions the country at the forefront of the global effort in combating Huntington’s disease.
The comprehensive report covers an array of regions and sub-segments within the market, shedding light on the dynamics at play:
Market Overview by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Rest of World
The study provides an exhaustive analysis including company overviews, recent developments, and revenue statistics which are essential for industry stakeholders.
Companies Fortifying Huntington’s Disease Treatment Landscape:
- H Lundbeck
- Pfizer Inc.
- Bausch Health Cos
- Teva Pharmaceutical Industries
- Dr Reddy’s Laboratories
- Sun Pharmaceutical Industries Limited
- Hikma Pharmaceuticals plc
- Alnylam Pharmaceuticals
- Novartis AG
- UniQure
Key Attributes
| Report Attribute | Details |
| No. of Pages | 170 |
| Forecast Period | 2022-2030 |
| Estimated Market Value (USD) in 2022 | $0.38 Billion |
| Forecasted Market Value (USD) by 2030 | $1.28 Billion |
| Compound Annual Growth Rate | 16.5% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/yzwc66
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Huntington Disease Treatment Market
